Series A - Joyn Bio
Investment Firm
Overview
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Announced Date
Mar 20, 2018
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Viking Global Investors |
 Ginkgo Bioworks |
Round Details and Background
Joyn Bio raised $100000000 on 2018-03-20 in Series A
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 20, 2018 |  Series A - Joyn Bio | 3 | - | 100.0M |
| Sep 14, 2017 | Series A - Joyn Bio | 3 | - | 100.0M |
Recent Activity
There is no recent news or activity for this profile.